(607766, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607767, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607768, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607769, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607770, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607771, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607772, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607773, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607774, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607775, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607776, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607777, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607778, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607779, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607780, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607781, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607782, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607783, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607784, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607785, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607786, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607787, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607788, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607789, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607790, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607791, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607792, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607793, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607794, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607795, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607796, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607797, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607798, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607799, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607800, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607801, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607802, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607803, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607804, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607805, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607806, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607807, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607808, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607809, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607810, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607811, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607812, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607813, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607814, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607815, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607816, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607817, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607818, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607819, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607820, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607821, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607822, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607823, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607824, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607825, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607826, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607827, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607828, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607829, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607830, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607831, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607832, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607833, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607834, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607835, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607836, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607837, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607838, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607839, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607840, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607841, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607842, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607843, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607844, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607845, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607846, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607847, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607848, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607849, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607850, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607851, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607852, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607853, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607854, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607855, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607856, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607857, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607858, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607859, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607860, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607861, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607862, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607863, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607864, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607865, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607866, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607867, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607868, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607869, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607870, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607871, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607872, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607873, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607874, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607875, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607876, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607877, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607878, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607879, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607880, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607881, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607882, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607883, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607884, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607885, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607886, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607887, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607888, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607889, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607890, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607891, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607892, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607893, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607894, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607895, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607896, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607897, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607898, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607899, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607900, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607901, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607902, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607903, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607904, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607905, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607906, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607907, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607908, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607909, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607910, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607911, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607912, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607913, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607914, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607915, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607916, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607917, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607918, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607919, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607920, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607921, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607922, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607923, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607924, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607925, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607926, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607927, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607928, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607929, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607930, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607931, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607932, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607933, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607934, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607935, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607936, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607937, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607938, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607939, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607940, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607941, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607942, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607943, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607944, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607945, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607946, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607947, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607948, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607949, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607950, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607951, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607952, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607953, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607954, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607955, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607956, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607957, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607958, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607959, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607960, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607961, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607962, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607963, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607964, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607965, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607966, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607967, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607968, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607969, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607970, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607971, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607972, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607973, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607974, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607975, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607976, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607977, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607978, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607979, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607980, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607981, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607982, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607983, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607984, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607985, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607986, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607987, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607988, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607989, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607990, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607991, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607992, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607993, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607994, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607995, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607996, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607997, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(607998, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(607999, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608000, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608001, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608002, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608003, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608004, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608005, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608006, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608007, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608008, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608009, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608010, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608011, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608012, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608013, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608014, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608015, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608016, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608017, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608018, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608019, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608020, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608021, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608022, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608023, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608024, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608025, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608026, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608027, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608028, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608029, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608030, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608031, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608032, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608033, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608034, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608035, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608036, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608037, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608038, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608039, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608040, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608041, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608042, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608043, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608044, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608045, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608046, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608047, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608048, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608049, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608050, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608051, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608052, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608053, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608054, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608055, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608056, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608057, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608058, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608059, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608060, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608061, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608062, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608063, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608064, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608065, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608066, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608067, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608068, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608069, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608070, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608071, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608072, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608073, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608074, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608075, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608076, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608077, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608078, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608079, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608080, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608081, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608082, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608083, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608084, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608085, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608086, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608087, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608088, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608089, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608090, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608091, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608092, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608093, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608094, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608095, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608096, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608097, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608098, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608099, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608100, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608101, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608102, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608103, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608104, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608105, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608106, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608107, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608108, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608109, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608110, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608111, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608112, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608113, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608114, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608115, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608116, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608117, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608118, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608119, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608120, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608121, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608122, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608123, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608124, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608125, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608126, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608127, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608128, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608129, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608130, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608131, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608132, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608133, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608134, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608135, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608136, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608137, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608138, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608139, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608140, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608141, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608142, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608143, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608144, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608145, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608146, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608147, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608148, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608149, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608150, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608151, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608152, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608153, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608154, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608155, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608156, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608157, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608158, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608159, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608160, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608161, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608162, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608163, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608164, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608165, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608166, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608167, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608168, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608169, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608170, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608171, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608172, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608173, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608174, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608175, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608176, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608177, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608178, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608179, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608180, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608181, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608182, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608183, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608184, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608185, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608186, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608187, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608188, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608189, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608190, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608191, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608192, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608193, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608194, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608195, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608196, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608197, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608198, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608199, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608200, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608201, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608202, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608203, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608204, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608205, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608206, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608207, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608208, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608209, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608210, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608211, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608212, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608213, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608214, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608215, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608216, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608217, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608218, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608219, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608220, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608221, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608222, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608223, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608224, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608225, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608226, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608227, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608228, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608229, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608230, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608231, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608232, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608233, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608234, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608235, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608236, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608237, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608238, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608239, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608240, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608241, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608242, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608243, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608244, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608245, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608246, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608247, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608248, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608249, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608250, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608251, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608252, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608253, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608254, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608255, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608256, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608257, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608258, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608259, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608260, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608261, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608262, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608263, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608264, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608265, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608266, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608267, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608268, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608269, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608270, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608271, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608272, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608273, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608274, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608275, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608276, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608277, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608278, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608279, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608280, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608281, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608282, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608283, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608284, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608285, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608286, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608287, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608288, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608289, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608290, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608291, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608292, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608293, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608294, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608295, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608296, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608297, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608298, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608299, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608300, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608301, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608302, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608303, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608304, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608305, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608306, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608307, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608308, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608309, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608310, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608311, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608312, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608313, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608314, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608315, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608316, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608317, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608318, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608319, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608320, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608321, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608322, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608323, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608324, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608325, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608326, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608327, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608328, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608329, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608330, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608331, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608332, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608333, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608334, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608335, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608336, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608337, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608338, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608339, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608340, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608341, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608342, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608343, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608344, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608345, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608346, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608347, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608348, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608349, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608350, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608351, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608352, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608353, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608354, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608355, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608356, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608357, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608358, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608359, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608360, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608361, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608362, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608363, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608364, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608365, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608366, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608367, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608368, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608369, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608370, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608371, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608372, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608373, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608374, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608375, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608376, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608377, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608378, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608379, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608380, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608381, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608382, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608383, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608384, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608385, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608386, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608387, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608388, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608389, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608390, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608391, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608392, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608393, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608394, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608395, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608396, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608397, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608398, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608399, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608400, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608401, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608402, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608403, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608404, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608405, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608406, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608407, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608408, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608409, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608410, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608411, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608412, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608413, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608414, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608415, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608416, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608417, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608418, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608419, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608420, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608421, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608422, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608423, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608424, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608425, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608426, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608427, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608428, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608429, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608430, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608431, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608432, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608433, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608434, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608435, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608436, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608437, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608438, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608439, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608440, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608441, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608442, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608443, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608444, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608445, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608446, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608447, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608448, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608449, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608450, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608451, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608452, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608453, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608454, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608455, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608456, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608457, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608458, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608459, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608460, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608461, 'HP:0025379', 'Anti-thyroid peroxidase antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608462, 'HP:0033524', 'Abnormal sperm axoneme morphology', 'MP:0005578', 'teratozoospermia', 0.4222222222222222, 11.607147267911277, 2.21377404292265, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(608463, 'HP:0033524', 'Abnormal sperm axoneme morphology', 'MP:0002208', 'abnormal germ cell morphology', 0.4146341463414634, 10.700256672302757, 2.106345601024391, 'UPHENO:0084966', 'abnormal germ cell morphology'),
(608464, 'HP:0033524', 'Abnormal sperm axoneme morphology', 'MP:0020550', 'multinucleated giant male germ cells', 0.4186046511627907, 11.607147267911277, 2.204269909307646, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(608465, 'HP:0033524', 'Abnormal sperm axoneme morphology', 'MP:0006362', 'abnormal male germ cell morphology', 0.42857142857142855, 11.607147267911277, 2.23035685177231, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(608466, 'HP:0033524', 'Abnormal sperm axoneme morphology', 'MP:0006378', 'abnormal spermatogonia morphology', 0.4090909090909091, 11.607147267911277, 2.179077425834586, 'UPHENO:0084945', 'abnormal male germ cell morphology'),
(608467, 'HP:0033524', 'Abnormal sperm axoneme morphology', 'MP:0001124', 'abnormal gametes', 0.42857142857142855, 10.791230332350247, 2.1505378396063337, 'UPHENO:0085194', 'abnormal gamete'),
(608468, 'HP:0001075', 'Atrophic scars', 'MP:0001199', 'thin skin', 0.40425531914893614, 7.4735768925632104, 1.7381695003328228, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(608469, 'HP:0001075', 'Atrophic scars', 'MP:0001221', 'epidermal atrophy', 0.40816326530612246, 10.052558416233639, 2.025607333085676, 'UPHENO:0013936', 'anatomical entity atrophy'),
(608470, 'HP:0001075', 'Atrophic scars', 'MP:0001215', 'skin hypoplasia', 0.4166666666666667, 7.4735768925632104, 1.7646502123370904, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(608471, 'HP:0001075', 'Atrophic scars', 'MP:0030584', 'skin atrophy', 0.45454545454545453, 10.052558416233639, 2.1376025670483405, 'UPHENO:0013936', 'anatomical entity atrophy'),
(608472, 'HP:0003142', 'Excessive purine production', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608473, 'HP:0003142', 'Excessive purine production', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608474, 'HP:0003142', 'Excessive purine production', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608475, 'HP:0003142', 'Excessive purine production', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608476, 'HP:0003142', 'Excessive purine production', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608477, 'HP:0003142', 'Excessive purine production', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608478, 'HP:0003142', 'Excessive purine production', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608479, 'HP:0003142', 'Excessive purine production', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608480, 'HP:0003142', 'Excessive purine production', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608481, 'HP:0003142', 'Excessive purine production', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(608482, 'HP:0003142', 'Excessive purine production', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608483, 'HP:0003142', 'Excessive purine production', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608484, 'HP:0003142', 'Excessive purine production', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608485, 'HP:0003142', 'Excessive purine production', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608486, 'HP:0003142', 'Excessive purine production', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608487, 'HP:0003142', 'Excessive purine production', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608488, 'HP:0003142', 'Excessive purine production', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608489, 'HP:0003142', 'Excessive purine production', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(608490, 'HP:0033280', 'Paratracheal lymphadenopathy', 'MP:0004106', 'lymphatic vessel hyperplasia', 0.42857142857142855, 10.052558416233639, 2.0756298613295647, 'UPHENO:0083530', 'anatomical entity hyperplasia'),
(608491, 'HP:0033280', 'Paratracheal lymphadenopathy', 'MP:0010200', 'enlarged lymphatic vessel', 0.425531914893617, 9.906707549770184, 2.0531975633009014, 'UPHENO:0075774', 'abnormal lymphatic part of lymphoid system'),
(608492, 'HP:0033280', 'Paratracheal lymphadenopathy', 'MP:0000702', 'enlarged lymph nodes', 0.4375, 13.285219173023913, 2.410867766634653, 'UPHENO:0001209', 'increased size of the lymph node'),
(608493, 'HP:0033280', 'Paratracheal lymphadenopathy', 'MP:0031094', 'organomegaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(608494, 'HP:0033280', 'Paratracheal lymphadenopathy', 'MP:0008102', 'lymph node hyperplasia', 0.46938775510204084, 14.384754846574829, 2.598466429478542, 'UPHENO:0083593', 'lymph node hyperplasia'),
(608495, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004463', 'basisphenoid bone foramen', 0.43283582089552236, 12.169741955603977, 2.2951035378475906, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608496, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004448', 'abnormal presphenoid bone morphology', 0.4032258064516129, 12.169741955603977, 2.2152096998605892, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608497, 'HP:0002680', 'J-shaped sella turcica', 'MP:0008818', 'abnormal interfrontal bone morphology', 0.42857142857142855, 8.373527591151573, 1.8943744830212697, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(608498, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004452', 'abnormal pterygoid process morphology', 0.4032258064516129, 12.169741955603977, 2.2152096998605892, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608499, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004459', 'small alisphenoid bone', 0.4264705882352941, 12.169741955603977, 2.2781652728628288, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608500, 'HP:0002680', 'J-shaped sella turcica', 'MP:0000100', 'abnormal ethmoid bone morphology', 0.4032258064516129, 9.312526519019649, 1.93779540089601, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(608501, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004462', 'small basisphenoid bone', 0.4264705882352941, 12.169741955603977, 2.2781652728628288, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608502, 'HP:0002680', 'J-shaped sella turcica', 'MP:0030303', 'small ethmoid bone', 0.417910447761194, 9.312526519019649, 1.9727650968504828, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(608503, 'HP:0002680', 'J-shaped sella turcica', 'MP:0030383', 'small presphenoid bone', 0.417910447761194, 12.169741955603977, 2.255185648633976, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608504, 'HP:0002680', 'J-shaped sella turcica', 'MP:0000104', 'abnormal sphenoid bone morphology', 0.4166666666666667, 12.169741955603977, 2.251827216914075, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608505, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004378', 'frontal bone foramen', 0.4153846153846154, 8.373527591151573, 1.865002557066065, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(608506, 'HP:0002680', 'J-shaped sella turcica', 'MP:0000106', 'abnormal basisphenoid bone morphology', 0.4126984126984127, 12.169741955603977, 2.2410785769417005, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608507, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004377', 'small frontal bone', 0.4090909090909091, 8.373527591151573, 1.8508198222847105, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(608508, 'HP:0002680', 'J-shaped sella turcica', 'MP:0004375', 'enlarged frontal bone', 0.4090909090909091, 8.373527591151573, 1.8508198222847105, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(608509, 'HP:0002680', 'J-shaped sella turcica', 'MP:0003235', 'abnormal alisphenoid bone morphology', 0.4126984126984127, 12.169741955603977, 2.2410785769417005, 'UPHENO:0086746', 'abnormal sphenoid bone morphology'),
(608510, 'HP:0002680', 'J-shaped sella turcica', 'MP:0030305', 'small cribriform plate', 0.4057971014492754, 9.312526519019649, 1.9439640605185282, 'UPHENO:0086750', 'abnormal basicranium morphology'),
(608511, 'HP:0002298', 'Absent hair', 'MP:0006364', 'absent awl hair', 0.5208333333333334, 13.285219173023913, 2.630472388364865, 'UPHENO:0008567', 'absent strand of hair'),
(608512, 'HP:0002298', 'Absent hair', 'MP:0003815', 'hairless', 0.5681818181818182, 13.285219173023913, 2.74743880453645, 'UPHENO:0008567', 'absent strand of hair'),
(608513, 'HP:0002298', 'Absent hair', 'MP:0009614', 'absent epidermis stratum spinosum', 0.425531914893617, 11.285219173023913, 2.1913970258013555, 'UPHENO:0025229', 'absent anatomical entity in the skin epidermis'),
(608514, 'HP:0002298', 'Absent hair', 'MP:0006363', 'absent auchene hairs', 0.5208333333333334, 13.285219173023913, 2.630472388364865, 'UPHENO:0008567', 'absent strand of hair'),
(608515, 'HP:0002298', 'Absent hair', 'MP:0001234', 'absent suprabasal layer', 0.4166666666666667, 11.285219173023913, 2.1684498277402295, 'UPHENO:0025229', 'absent anatomical entity in the skin epidermis'),
(608516, 'HP:0002298', 'Absent hair', 'MP:0001232', 'absent epidermis stratum basale', 0.4166666666666667, 11.285219173023913, 2.1684498277402295, 'UPHENO:0025229', 'absent anatomical entity in the skin epidermis'),
(608517, 'HP:0002298', 'Absent hair', 'MP:0009560', 'absent epidermis stratum granulosum', 0.425531914893617, 11.285219173023913, 2.1913970258013555, 'UPHENO:0025229', 'absent anatomical entity in the skin epidermis'),
(608518, 'HP:0002298', 'Absent hair', 'MP:0006365', 'absent guard hair', 0.5208333333333334, 13.285219173023913, 2.630472388364865, 'UPHENO:0008567', 'absent strand of hair'),
(608519, 'HP:0002298', 'Absent hair', 'MP:0000378', 'absent hair follicles', 0.40384615384615385, 11.285219173023913, 2.1348284142611043, 'UPHENO:0025229', 'absent anatomical entity in the skin epidermis'),
(608520, 'HP:0002298', 'Absent hair', 'MP:0000408', 'absent duvet hair', 0.5208333333333334, 13.285219173023913, 2.630472388364865, 'UPHENO:0008567', 'absent strand of hair'),
(608521, 'HP:0002298', 'Absent hair', 'MP:0006366', 'absent zigzag hairs', 0.5208333333333334, 13.285219173023913, 2.630472388364865, 'UPHENO:0008567', 'absent strand of hair'),
(608522, 'HP:0006361', 'Irregular femoral epiphysis', 'MP:0008158', 'increased diameter of femur', 0.4050632911392405, 11.359219754467691, 2.1450414771091393, 'UPHENO:0020967', 'abnormal femur morphology'),
(608523, 'HP:0006361', 'Irregular femoral epiphysis', 'MP:0030825', 'decreased femur size', 0.4155844155844156, 11.359219754467691, 2.17272057641, 'UPHENO:0020967', 'abnormal femur morphology'),
(608524, 'HP:0006361', 'Irregular femoral epiphysis', 'MP:0008152', 'decreased diameter of femur', 0.4050632911392405, 11.359219754467691, 2.1450414771091393, 'UPHENO:0020967', 'abnormal femur morphology'),
(608525, 'HP:0006361', 'Irregular femoral epiphysis', 'MP:0030827', 'femur fracture', 0.42105263157894735, 11.359219754467691, 2.1869680771109086, 'UPHENO:0020967', 'abnormal femur morphology'),
(608526, 'HP:0006361', 'Irregular femoral epiphysis', 'MP:0030823', 'increased femur size', 0.4155844155844156, 11.359219754467691, 2.17272057641, 'UPHENO:0020967', 'abnormal femur morphology'),
(608527, 'HP:0000805', 'Enuresis', 'MP:0001761', 'abnormal urination pattern', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(608528, 'HP:0000805', 'Enuresis', 'MP:0003621', 'dysuria', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(608529, 'HP:0000805', 'Enuresis', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608530, 'HP:0000805', 'Enuresis', 'MP:0010386', 'abnormal urinary bladder physiology', 0.5333333333333333, 13.062826751687464, 2.6394773979394697, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(608531, 'HP:0000805', 'Enuresis', 'MP:0009646', 'urinary bladder inflammation', 0.42105263157894735, 13.062826751687464, 2.345237211809901, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(608532, 'HP:0000805', 'Enuresis', 'MP:0011431', 'increased urine flow rate', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(608533, 'HP:0000805', 'Enuresis', 'MP:0014037', 'stranguria', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(608534, 'HP:0000805', 'Enuresis', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608535, 'HP:0000805', 'Enuresis', 'MP:0001756', 'abnormal urination', 0.43333333333333335, 6.416088053379619, 1.6674246079301962, 'UPHENO:0002832', 'abnormal renal system'),
(608536, 'HP:0000805', 'Enuresis', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608537, 'HP:0000805', 'Enuresis', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608538, 'HP:0000805', 'Enuresis', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608539, 'HP:0000805', 'Enuresis', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608540, 'HP:0000805', 'Enuresis', 'MP:0009643', 'abnormal urine homeostasis', 0.40625, 6.416088053379619, 1.6144769343925203, 'UPHENO:0002832', 'abnormal renal system'),
(608541, 'HP:0000805', 'Enuresis', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608542, 'HP:0000805', 'Enuresis', 'MP:0011432', 'decreased urine flow rate', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(608543, 'HP:0000805', 'Enuresis', 'MP:0003280', 'urinary incontinence', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(608544, 'HP:0000805', 'Enuresis', 'MP:0005302', 'neurogenic bladder', 0.42105263157894735, 13.062826751687464, 2.345237211809901, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(608545, 'HP:0000805', 'Enuresis', 'MP:0011923', 'abnormal bladder urine volume', 0.5161290322580645, 13.062826751687464, 2.596556205804759, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(608546, 'HP:0000805', 'Enuresis', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4482758620689655, 6.416088053379619, 1.6959296575150573, 'UPHENO:0002832', 'abnormal renal system'),
(608547, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0001942', 'abnormal lung volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(608548, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0001958', 'emphysema', 0.40476190476190477, 9.150450616995217, 1.9245139181530309, 'UPHENO:0086908', 'abnormal lung morphology'),
(608549, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0010857', 'pulmonary necrosis', 0.4318181818181818, 9.915985363358194, 2.0692759048858225, 'UPHENO:0019970', 'abnormal lung morphology'),
(608550, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0010937', 'increased total lung capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(608551, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002337', 'abnormal whole-body plethysmography', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608552, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002311', 'abnormal inspiratory capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608553, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608554, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0003828', 'pulmonary edema', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(608555, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0004881', 'abnormal lung size', 0.4473684210526316, 9.915985363358194, 2.1062048132094278, 'UPHENO:0019970', 'abnormal lung morphology'),
(608556, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002133', 'abnormal respiratory system physiology', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(608557, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002306', 'abnormal functional residual capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608558, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0006050', 'pulmonary fibrosis', 0.4473684210526316, 9.915985363358194, 2.1062048132094278, 'UPHENO:0019970', 'abnormal lung morphology'),
(608559, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002309', 'abnormal vital capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608560, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0010938', 'decreased total lung capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(608561, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0005629', 'abnormal lung weight', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(608562, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0003641', 'small lung', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(608563, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002304', 'abnormal total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(608564, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002308', 'abnormal residual volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608565, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0005585', 'increased tidal volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(608566, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0002313', 'abnormal tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(608567, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0005586', 'decreased tidal volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(608568, 'HP:0025392', 'Nodular pattern on pulmonary HRCT', 'MP:0011162', 'abnormal wet-to-dry lung weight ratio', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(608569, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608570, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608571, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608572, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608573, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608574, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608575, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608576, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608577, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608578, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608579, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608580, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608581, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608582, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608583, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608584, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608585, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608586, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608587, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608588, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608589, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608590, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608591, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608592, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608593, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608594, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608595, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608596, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608597, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608598, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608599, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608600, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608601, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608602, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608603, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608604, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608605, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608606, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608607, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608608, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608609, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608610, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608611, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608612, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608613, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608614, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608615, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608616, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608617, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608618, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608619, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608620, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608621, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608622, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608623, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608624, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608625, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608626, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608627, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608628, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608629, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608630, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608631, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608632, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608633, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608634, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608635, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608636, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608637, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608638, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608639, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608640, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608641, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608642, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608643, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608644, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608645, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608646, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608647, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608648, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608649, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608650, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608651, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608652, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608653, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608654, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608655, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608656, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608657, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608658, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608659, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608660, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608661, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608662, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608663, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608664, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608665, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608666, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608667, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608668, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608669, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608670, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608671, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608672, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608673, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608674, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608675, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608676, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608677, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608678, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608679, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608680, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608681, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608682, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608683, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608684, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608685, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608686, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608687, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608688, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608689, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608690, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608691, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608692, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608693, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608694, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608695, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608696, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608697, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608698, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608699, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608700, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608701, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608702, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608703, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608704, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608705, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608706, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608707, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608708, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608709, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608710, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608711, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608712, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608713, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608714, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608715, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608716, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608717, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608718, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608719, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608720, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608721, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608722, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608723, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608724, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608725, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608726, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608727, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608728, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608729, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608730, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608731, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608732, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608733, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608734, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608735, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608736, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608737, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608738, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608739, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608740, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608741, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608742, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608743, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608744, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608745, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608746, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608747, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608748, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608749, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608750, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608751, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608752, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608753, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608754, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608755, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608756, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608757, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608758, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608759, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608760, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608761, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608762, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608763, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608764, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608765, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608766, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608767, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608768, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608769, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608770, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608771, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608772, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608773, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608774, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608775, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608776, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608777, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608778, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608779, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608780, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608781, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608782, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608783, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608784, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608785, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608786, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608787, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608788, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608789, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608790, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608791, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608792, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608793, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608794, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608795, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608796, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608797, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608798, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608799, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608800, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608801, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608802, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608803, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608804, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608805, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608806, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608807, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608808, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608809, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608810, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608811, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608812, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608813, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608814, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608815, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608816, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608817, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608818, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608819, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608820, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608821, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608822, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608823, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608824, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608825, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608826, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608827, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608828, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608829, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608830, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608831, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608832, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608833, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608834, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608835, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608836, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608837, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608838, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608839, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608840, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608841, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608842, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608843, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608844, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608845, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608846, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608847, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608848, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608849, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608850, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608851, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608852, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608853, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608854, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608855, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608856, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608857, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608858, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608859, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608860, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608861, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608862, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608863, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608864, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608865, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608866, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608867, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608868, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608869, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608870, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608871, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608872, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608873, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608874, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608875, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608876, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608877, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608878, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608879, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608880, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608881, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608882, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608883, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608884, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608885, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608886, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608887, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608888, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608889, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608890, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608891, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608892, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608893, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608894, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608895, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608896, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608897, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608898, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608899, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608900, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608901, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608902, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608903, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608904, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608905, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608906, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608907, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608908, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608909, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608910, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608911, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608912, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608913, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608914, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608915, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608916, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608917, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608918, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608919, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608920, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608921, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608922, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608923, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608924, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608925, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608926, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608927, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608928, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608929, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608930, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608931, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608932, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608933, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608934, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608935, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608936, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608937, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608938, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608939, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608940, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608941, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608942, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608943, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608944, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608945, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608946, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608947, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608948, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608949, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608950, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608951, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608952, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608953, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608954, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608955, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608956, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608957, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608958, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608959, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608960, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608961, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608962, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608963, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608964, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608965, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608966, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608967, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608968, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608969, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608970, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608971, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608972, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608973, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608974, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608975, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608976, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608977, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608978, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608979, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608980, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608981, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608982, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608983, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608984, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608985, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608986, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608987, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608988, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608989, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608990, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608991, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608992, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608993, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608994, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608995, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608996, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608997, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(608998, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(608999, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609000, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609001, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609002, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609003, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609004, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609005, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609006, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609007, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609008, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609009, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609010, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609011, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609012, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609013, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609014, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609015, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609016, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609017, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609018, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609019, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609020, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609021, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609022, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609023, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609024, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609025, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609026, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609027, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609028, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609029, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609030, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609031, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609032, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609033, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609034, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609035, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609036, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609037, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609038, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609039, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609040, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609041, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609042, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609043, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609044, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609045, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609046, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609047, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609048, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609049, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609050, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609051, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609052, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609053, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609054, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609055, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609056, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609057, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609058, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609059, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609060, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609061, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609062, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609063, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609064, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609065, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609066, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609067, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609068, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609069, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609070, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609071, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609072, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609073, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609074, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609075, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609076, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609077, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609078, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609079, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609080, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609081, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609082, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609083, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609084, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609085, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609086, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609087, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609088, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609089, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609090, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609091, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609092, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609093, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609094, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609095, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609096, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609097, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609098, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609099, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609100, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609101, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609102, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609103, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609104, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609105, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609106, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609107, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609108, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609109, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609110, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609111, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609112, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609113, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609114, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609115, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609116, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609117, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609118, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609119, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609120, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609121, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609122, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609123, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609124, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609125, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609126, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609127, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609128, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609129, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609130, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609131, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609132, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609133, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609134, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609135, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609136, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609137, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609138, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609139, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609140, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609141, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609142, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609143, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609144, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609145, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609146, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609147, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609148, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609149, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609150, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609151, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609152, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609153, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609154, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609155, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609156, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609157, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609158, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609159, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609160, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609161, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609162, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609163, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609164, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609165, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609166, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609167, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609168, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609169, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609170, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609171, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609172, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609173, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609174, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609175, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609176, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609177, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609178, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609179, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609180, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609181, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609182, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609183, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609184, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609185, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609186, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609187, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609188, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609189, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609190, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609191, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609192, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609193, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609194, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609195, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609196, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609197, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609198, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609199, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609200, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609201, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609202, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609203, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609204, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609205, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609206, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609207, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609208, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609209, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609210, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609211, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609212, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609213, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609214, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609215, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609216, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609217, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609218, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609219, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609220, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609221, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609222, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609223, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609224, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609225, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609226, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609227, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609228, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609229, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609230, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609231, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609232, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609233, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609234, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609235, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609236, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609237, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609238, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609239, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609240, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609241, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609242, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609243, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609244, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609245, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609246, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609247, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609248, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609249, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609250, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609251, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609252, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609253, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609254, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609255, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609256, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609257, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609258, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609259, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609260, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609261, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609262, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609263, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609264, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609265, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609266, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609267, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609268, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609269, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609270, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609271, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609272, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609273, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609274, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609275, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609276, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609277, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609278, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609279, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609280, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609281, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609282, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609283, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609284, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609285, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609286, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609287, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609288, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609289, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609290, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609291, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609292, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609293, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609294, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609295, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609296, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609297, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609298, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609299, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609300, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609301, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609302, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609303, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609304, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609305, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609306, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609307, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609308, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609309, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609310, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609311, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609312, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609313, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609314, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609315, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609316, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609317, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609318, 'HP:5000026', 'Anti-neurexin-3alpha antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609319, 'HP:0008569', 'Microtia, second degree', 'MP:0020084', 'short ears', 0.4098360655737705, 14.607147267911275, 2.446739823834444, 'UPHENO:0069196', 'decreased size of the external ear'),
(609320, 'HP:0008569', 'Microtia, second degree', 'MP:0003679', 'ear lobe hypoplasia', 0.45, 10.255471829629862, 2.1482463367438656, 'UPHENO:0086699', 'abnormal external ear morphology'),
(609321, 'HP:0008569', 'Microtia, second degree', 'MP:0000022', 'abnormal ear shape', 0.44642857142857145, 11.115294171581601, 2.2275962152121513, 'UPHENO:0005986', 'abnormal shape of external ear'),
(609322, 'HP:0008569', 'Microtia, second degree', 'MP:0030297', 'outer ear hypoplasia', 0.5263157894736842, 15.607147267911275, 2.8660579260968846, 'UPHENO:0081119', 'external ear hypoplasia'),
(609323, 'HP:0008569', 'Microtia, second degree', 'MP:0006286', 'inner ear hypoplasia', 0.4098360655737705, 8.202005804774931, 1.8334333336236104, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(609324, 'HP:0008569', 'Microtia, second degree', 'MP:0003735', 'cup-shaped ears', 0.4032258064516129, 11.115294171581601, 2.117067182751389, 'UPHENO:0005986', 'abnormal shape of external ear'),
(609325, 'HP:0008569', 'Microtia, second degree', 'MP:0000018', 'small ears', 0.44642857142857145, 14.607147267911275, 2.553634250917776, 'UPHENO:0069196', 'decreased size of the external ear'),
(609326, 'HP:0030652', 'Vitreous haze', 'MP:0006225', 'ocular rupture', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609327, 'HP:0030652', 'Vitreous haze', 'MP:0002697', 'abnormal eye size', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609328, 'HP:0030652', 'Vitreous haze', 'MP:0002699', 'abnormal vitreous body morphology', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(609329, 'HP:0030652', 'Vitreous haze', 'MP:0006200', 'vitreous body deposition', 0.41509433962264153, 7.832360208310102, 1.803099661237597, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(609330, 'HP:0030652', 'Vitreous haze', 'MP:0001289', 'persistence of hyaloid vascular system', 0.4074074074074074, 7.832360208310102, 1.786326276565555, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(609331, 'HP:0030652', 'Vitreous haze', 'MP:0003381', 'vitreal fibroplasia', 0.41509433962264153, 7.832360208310102, 1.803099661237597, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(609332, 'HP:0030652', 'Vitreous haze', 'MP:0006209', 'calcified intraocular region', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609333, 'HP:0030774', 'Mitochondrial swelling', 'MP:0020851', 'abnormal vacuole morphology', 0.40540540540540543, 9.356059413574362, 1.9475618243221893, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609334, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011631', 'decreased mitochondrial size', 0.40476190476190477, 12.906707549770184, 2.28563853923796, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609335, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011743', 'abnormal Golgi apparatus morphology', 0.40540540540540543, 9.356059413574362, 1.9475618243221893, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609336, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011629', 'decreased mitochondrial number', 0.4146341463414634, 12.906707549770184, 2.3133442603680674, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609337, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011635', 'abnormal mitochondrial crista morphology', 0.4146341463414634, 12.906707549770184, 2.3133442603680674, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609338, 'HP:0030774', 'Mitochondrial swelling', 'MP:0014238', 'abnormal ribosome morphology', 0.40540540540540543, 9.356059413574362, 1.9475618243221893, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609339, 'HP:0030774', 'Mitochondrial swelling', 'MP:0020378', 'abnormal cell cytoskeleton morphology', 0.40540540540540543, 9.356059413574362, 1.9475618243221893, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609340, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011628', 'increased mitochondrial number', 0.4146341463414634, 12.906707549770184, 2.3133442603680674, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609341, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011633', 'abnormal mitochondrial shape', 0.5135135135135135, 15.607147267911275, 2.830985875886341, 'UPHENO:0005993', 'abnormal shape of mitochondrion'),
(609342, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011637', 'abnormal mitochondrial matrix morphology', 0.4473684210526316, 12.906707549770184, 2.402926003340254, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609343, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011634', 'abnormal mitochondrial inner membrane morphology', 0.4358974358974359, 12.906707549770184, 2.3719192074821818, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609344, 'HP:0030774', 'Mitochondrial swelling', 'MP:0014239', 'abnormal intracellular organelle morphology', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609345, 'HP:0030774', 'Mitochondrial swelling', 'MP:0006035', 'abnormal mitochondrial morphology', 0.4722222222222222, 12.906707549770184, 2.4687717838481564, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609346, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011630', 'increased mitochondrial size', 0.40476190476190477, 12.906707549770184, 2.28563853923796, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609347, 'HP:0030774', 'Mitochondrial swelling', 'MP:0014010', 'abnormal peroxisome morphology', 0.40540540540540543, 9.356059413574362, 1.9475618243221893, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609348, 'HP:0030774', 'Mitochondrial swelling', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.40625, 7.297292005324488, 1.7217795669489964, 'UPHENO:0067691', 'abnormal morphology of cellular_component'),
(609349, 'HP:0030774', 'Mitochondrial swelling', 'MP:0011636', 'disorganized mitochondrial cristae', 0.40476190476190477, 12.906707549770184, 2.28563853923796, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(609350, 'HP:0030774', 'Mitochondrial swelling', 'MP:0009378', 'abnormal endoplasmic reticulum morphology', 0.40540540540540543, 9.356059413574362, 1.9475618243221893, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(609351, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0008158', 'increased diameter of femur', 0.49230769230769234, 11.359219754467691, 2.364789898434519, 'UPHENO:0020967', 'abnormal femur morphology'),
(609352, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030792', 'large femur head', 0.43478260869565216, 10.700256672302757, 2.1569157400549637, 'UPHENO:0087558', 'abnormal femur morphology'),
(609353, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0002764', 'short tibia', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(609354, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0002765', 'short fibula', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(609355, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030825', 'decreased femur size', 0.5079365079365079, 11.359219754467691, 2.402032975412227, 'UPHENO:0020967', 'abnormal femur morphology'),
(609356, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0000559', 'abnormal femur morphology', 0.41379310344827586, 10.700256672302757, 2.104208263486597, 'UPHENO:0087558', 'abnormal femur morphology'),
(609357, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0003109', 'short femur', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(609358, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030823', 'increased femur size', 0.5079365079365079, 11.359219754467691, 2.402032975412227, 'UPHENO:0020967', 'abnormal femur morphology'),
(609359, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030824', 'increased femur weight', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(609360, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030794', 'broad femur neck', 0.42857142857142855, 10.700256672302757, 2.1414537791252353, 'UPHENO:0087558', 'abnormal femur morphology'),
(609361, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0000482', 'long fibula', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(609362, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0004357', 'long tibia', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(609363, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030826', 'decreased femur weight', 0.4383561643835616, 11.359219754467691, 2.2314533385124684, 'UPHENO:0020967', 'abnormal femur morphology'),
(609364, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0004371', 'bowed femur', 0.4155844155844156, 11.359219754467691, 2.17272057641, 'UPHENO:0020967', 'abnormal femur morphology'),
(609365, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030793', 'short femur neck', 0.4225352112676056, 10.700256672302757, 2.1263196405171665, 'UPHENO:0087558', 'abnormal femur morphology'),
(609366, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0008152', 'decreased diameter of femur', 0.49230769230769234, 11.359219754467691, 2.364789898434519, 'UPHENO:0020967', 'abnormal femur morphology'),
(609367, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030791', 'club-shaped femur', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(609368, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0030827', 'femur fracture', 0.5161290322580645, 11.359219754467691, 2.421326722910417, 'UPHENO:0020967', 'abnormal femur morphology'),
(609369, 'HP:0006406', 'Club-shaped proximal femur', 'MP:0004348', 'long femur', 0.45714285714285713, 11.359219754467691, 2.27876856514016, 'UPHENO:0020967', 'abnormal femur morphology'),
(609370, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0000108', 'midline facial cleft', 0.4444444444444444, 13.437222266468964, 2.4437877946125592, 'UPHENO:0041242', 'split face'),
(609371, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0031501', 'abnormal mouth shape', 0.4126984126984127, 7.503859459499253, 1.7597814887216283, 'UPHENO:0076800', 'abnormal mouth morphology'),
(609372, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0030074', 'coarse facial features', 0.423728813559322, 12.700256672302759, 2.3197984161676013, 'UPHENO:0005983', 'abnormal shape of face'),
(609373, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0008798', 'lateral facial cleft', 0.4666666666666667, 13.437222266468964, 2.5041373213847886, 'UPHENO:0041242', 'split face'),
(609374, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0030071', 'abnormal face shape', 0.43103448275862066, 12.700256672302759, 2.3397112141560847, 'UPHENO:0005983', 'abnormal shape of face'),
(609375, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0008799', 'oblique facial cleft', 0.4666666666666667, 13.437222266468964, 2.5041373213847886, 'UPHENO:0041242', 'split face'),
(609376, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0003749', 'down-turned corners of mouth', 0.40625, 7.503859459499253, 1.745979067864667, 'UPHENO:0076800', 'abnormal mouth morphology'),
(609377, 'HP:0031579', 'Tessier number 7 facial cleft', 'MP:0008797', 'facial cleft', 0.4745762711864407, 13.437222266468964, 2.5252696565563557, 'UPHENO:0041242', 'split face'),
(609378, 'HP:0003153', 'Cystathioninuria', 'MP:0030620', 'valinuria', 0.4823529411764706, 11.226325483970346, 2.3270262387427993, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609379, 'HP:0003153', 'Cystathioninuria', 'MP:0030689', 'cystathioninuria', 0.6025641025641025, 16.607147267911277, 3.1633638408565723, 'UPHENO:0068235', 'increased level of cystathionine in urine'),
(609380, 'HP:0003153', 'Cystathioninuria', 'MP:0011765', 'oroticaciduria', 0.4666666666666667, 10.47786425096631, 2.211259818244857, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(609381, 'HP:0003153', 'Cystathioninuria', 'MP:0011516', 'aspartylglucosaminuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609382, 'HP:0003153', 'Cystathioninuria', 'MP:0013730', 'glutathionuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609383, 'HP:0003153', 'Cystathioninuria', 'MP:0020406', 'hyperthreoninuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609384, 'HP:0003153', 'Cystathioninuria', 'MP:0030682', 'hydroxyprolinuria', 0.4823529411764706, 11.226325483970346, 2.3270262387427993, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609385, 'HP:0003153', 'Cystathioninuria', 'MP:0020404', 'prolinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609386, 'HP:0003153', 'Cystathioninuria', 'MP:0030617', 'hyperglutaminuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609387, 'HP:0003153', 'Cystathioninuria', 'MP:0020400', 'cystinuria', 0.5125, 11.226325483970346, 2.3986437439800854, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609388, 'HP:0003153', 'Cystathioninuria', 'MP:0030613', 'dicarboxylic aciduria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(609389, 'HP:0003153', 'Cystathioninuria', 'MP:0011470', 'increased urine creatinine level', 0.4230769230769231, 11.094077685671904, 2.166482922072182, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(609390, 'HP:0003153', 'Cystathioninuria', 'MP:0020405', 'taurinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609391, 'HP:0003153', 'Cystathioninuria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5060240963855421, 11.226325483970346, 2.3834410436920983, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609392, 'HP:0003153', 'Cystathioninuria', 'MP:0020401', 'argininuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609393, 'HP:0003153', 'Cystathioninuria', 'MP:0030616', 'hyperglycinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609394, 'HP:0003153', 'Cystathioninuria', 'MP:0011654', 'histidinuria', 0.5125, 11.226325483970346, 2.3986437439800854, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609395, 'HP:0003153', 'Cystathioninuria', 'MP:0030618', 'tryptophanuria', 0.5125, 11.226325483970346, 2.3986437439800854, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609396, 'HP:0003153', 'Cystathioninuria', 'MP:0003311', 'aminoaciduria', 0.5333333333333333, 11.226325483970346, 2.44691103055482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609397, 'HP:0003153', 'Cystathioninuria', 'MP:0020403', 'lysinuria', 0.4823529411764706, 11.226325483970346, 2.3270262387427993, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609398, 'HP:0003153', 'Cystathioninuria', 'MP:0020402', 'ornithinuria', 0.5060240963855421, 11.226325483970346, 2.3834410436920983, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(609399, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000830', 'abnormal diencephalon morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609400, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609401, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0006291', 'aprosencephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609402, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000914', 'exencephaly', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609403, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000844', 'abnormal pontine flexure morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609404, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009678', 'abnormal spinal cord lateral column morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609405, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609406, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609407, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0004250', 'tau protein deposits', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609408, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014067', 'Hirano bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609409, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009686', 'abnormal spinal cord medial motor column morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609410, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0004998', 'decreased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609411, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003632', 'abnormal nervous system morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609412, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000955', 'abnormal spinal cord morphology', 0.5, 5.838687225017717, 1.7086086774065203, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609413, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0001889', 'delayed brain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609414, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008857', 'myelencephalic blebs', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609415, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0013564', 'abnormal sensory circumventricular organ morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609416, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0004203', 'abnormal cranial flexure morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609417, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009677', 'abnormal spinal cord dorsal column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609418, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002184', 'abnormal innervation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609419, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0006100', 'abnormal tegmentum morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609420, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009023', 'abnormal spinal cord meninges morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609421, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0021142', 'abnormal brain N-acetyl-L-aspartic acid level', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609422, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609423, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0005112', 'abnormal spinal cord ventral horn morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609424, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0020370', 'abnormal glymphatic system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609425, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008025', 'brain vacuoles', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609426, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0012260', 'encephalomeningocele', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609427, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0013934', 'supratentorial ventricles enlargement', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609428, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609429, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000783', 'abnormal forebrain morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609430, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0012711', 'diplomyelia', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609431, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0013935', 'basal brain tissue herniation', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609432, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003634', 'abnormal glial cell morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609433, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009024', 'abnormal brain arachnoid mater morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609434, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002778', 'meroanencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609435, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0005623', 'abnormal meninges morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609436, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009022', 'abnormal brain meninges morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609437, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000897', 'abnormal midbrain morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609438, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003864', 'abnormal midbrain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609439, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009682', 'abnormal anterior corticospinal tract morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609440, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002199', 'abnormal brain commissure morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609441, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009037', 'abnormal subarachnoid space development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609442, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609443, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609444, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0012132', 'abnormal midbrain-hindbrain boundary morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609445, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009032', 'abnormal subarachnoid cistern morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609446, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0006007', 'abnormal basal ganglion morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609447, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008493', 'alpha-synuclein inclusion body', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609448, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014062', 'nervous system inclusion bodies', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609449, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0001891', 'hydrocephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609450, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0012545', 'syringomyelia', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609451, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0004997', 'increased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609452, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002653', 'abnormal ependyma morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609453, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009695', 'abnormal spinal cord ventral commissure morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609454, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009637', 'abnormal pretectal region morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609455, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003329', 'amyloid beta deposits', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609456, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000849', 'abnormal cerebellum morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609457, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000847', 'abnormal metencephalon morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609458, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014277', 'alobar holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609459, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0001890', 'anencephaly', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609460, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009694', 'abnormal spinal cord commissure morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609461, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0021002', 'brain lesion', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609462, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000787', 'abnormal telencephalon morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609463, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000778', 'abnormal nervous system tract morphology', 0.5, 5.838687225017717, 1.7086086774065203, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609464, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000917', 'obstructive hydrocephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609465, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0010744', 'abnormal cervical flexure morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609466, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003232', 'abnormal forebrain development', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609467, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014065', 'Lewy bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609468, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002152', 'abnormal brain morphology', 0.5, 5.838687225017717, 1.7086086774065203, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609469, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000841', 'abnormal hindbrain morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609470, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609471, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0030014', 'calcified brain', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609472, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000913', 'abnormal brain development', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609473, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0001893', 'non-obstructive hydrocephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609474, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609475, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0010151', 'abnormal spinal cord ependymal layer morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609476, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0006108', 'abnormal hindbrain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609477, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008026', 'abnormal brain white matter morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609478, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609479, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003861', 'abnormal nervous system development', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609480, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0013306', 'abnormal tela choroidea morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609481, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0006282', 'abnormal spinal cord dorsal horn morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609482, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0005277', 'abnormal brainstem morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609483, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014278', 'semilobar holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609484, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014064', 'argyrophilic inclusion bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609485, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0004996', 'abnormal CNS synapse formation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609486, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000771', 'abnormal brain size', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609487, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008232', 'abnormal cingulum morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609488, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0002924', 'delayed CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609489, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0003214', 'neurofibrillary tangles', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609490, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609491, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014066', 'Rosenthal fibers', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609492, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0004166', 'abnormal limbic system morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609493, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009804', 'abnormal interventricular foramen morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609494, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609495, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014061', 'ethmocephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609496, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009679', 'abnormal spinal cord ventral column morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609497, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0000822', 'abnormal brain ventricle morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609498, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014063', 'Lafora bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609499, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609500, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0008540', 'abnormal cerebral hemisphere morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609501, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609502, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609503, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0014276', 'lobar holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609504, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0005157', 'holoprosencephaly', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609505, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(609506, 'HP:0012510', 'Extra-axial cerebrospinal fluid accumulation', 'MP:0020452', 'abnormal axon radial sorting', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(609507, 'HP:0032517', 'Majocchis granuloma', 'MP:0005001', 'abnormal clonal deletion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609508, 'HP:0032517', 'Majocchis granuloma', 'MP:0005000', 'abnormal immune tolerance', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609509, 'HP:0032517', 'Majocchis granuloma', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609510, 'HP:0032517', 'Majocchis granuloma', 'MP:0001194', 'dermatitis', 0.41025641025641024, 7.400946880077414, 1.7424941605408435, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609511, 'HP:0032517', 'Majocchis granuloma', 'MP:0003009', 'abnormal cytokine secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609512, 'HP:0032517', 'Majocchis granuloma', 'MP:0001845', 'abnormal inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609513, 'HP:0032517', 'Majocchis granuloma', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609514, 'HP:0032517', 'Majocchis granuloma', 'MP:0004752', 'decreased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609515, 'HP:0032517', 'Majocchis granuloma', 'MP:0001835', 'abnormal antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609516, 'HP:0032517', 'Majocchis granuloma', 'MP:0020155', 'enhanced humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609517, 'HP:0032517', 'Majocchis granuloma', 'MP:0001800', 'abnormal humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609518, 'HP:0032517', 'Majocchis granuloma', 'MP:0002419', 'abnormal innate immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609519, 'HP:0032517', 'Majocchis granuloma', 'MP:0004751', 'increased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609520, 'HP:0032517', 'Majocchis granuloma', 'MP:0002499', 'chronic inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609521, 'HP:0032517', 'Majocchis granuloma', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609522, 'HP:0032517', 'Majocchis granuloma', 'MP:0004947', 'skin inflammation', 0.42105263157894735, 7.400946880077414, 1.7652728287810344, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609523, 'HP:0032517', 'Majocchis granuloma', 'MP:0020002', 'increased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609524, 'HP:0032517', 'Majocchis granuloma', 'MP:0005005', 'abnormal self tolerance', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609525, 'HP:0032517', 'Majocchis granuloma', 'MP:0005025', 'abnormal response to infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609526, 'HP:0032517', 'Majocchis granuloma', 'MP:0002498', 'abnormal acute inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609527, 'HP:0032517', 'Majocchis granuloma', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609528, 'HP:0032517', 'Majocchis granuloma', 'MP:0003762', 'abnormal immune organ physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609529, 'HP:0032517', 'Majocchis granuloma', 'MP:0020001', 'decreased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609530, 'HP:0032517', 'Majocchis granuloma', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609531, 'HP:0032517', 'Majocchis granuloma', 'MP:0020000', 'abnormal response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609532, 'HP:0032517', 'Majocchis granuloma', 'MP:0001876', 'decreased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609533, 'HP:0032517', 'Majocchis granuloma', 'MP:0010071', 'abnormal pruritus', 0.4117647058823529, 6.904974582545727, 1.686186474891512, 'UPHENO:0003811', 'abnormal skin of body'),
(609534, 'HP:0032517', 'Majocchis granuloma', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609535, 'HP:0032517', 'Majocchis granuloma', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.41025641025641024, 7.400946880077414, 1.7424941605408435, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609536, 'HP:0032517', 'Majocchis granuloma', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609537, 'HP:0032517', 'Majocchis granuloma', 'MP:0002420', 'abnormal adaptive immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609538, 'HP:0032517', 'Majocchis granuloma', 'MP:0005501', 'abnormal skin physiology', 0.42424242424242425, 6.904974582545727, 1.7115440853894242, 'UPHENO:0003811', 'abnormal skin of body'),
(609539, 'HP:0032517', 'Majocchis granuloma', 'MP:0005275', 'abnormal skin tensile strength', 0.4117647058823529, 6.904974582545727, 1.686186474891512, 'UPHENO:0003811', 'abnormal skin of body'),
(609540, 'HP:0032517', 'Majocchis granuloma', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.41025641025641024, 7.400946880077414, 1.7424941605408435, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609541, 'HP:0032517', 'Majocchis granuloma', 'MP:0009473', 'abnormal skin exfoliation', 0.4117647058823529, 6.904974582545727, 1.686186474891512, 'UPHENO:0003811', 'abnormal skin of body'),
(609542, 'HP:0032517', 'Majocchis granuloma', 'MP:0020154', 'impaired humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609543, 'HP:0032517', 'Majocchis granuloma', 'MP:0001846', 'increased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609544, 'HP:0032517', 'Majocchis granuloma', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609545, 'HP:0032517', 'Majocchis granuloma', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609546, 'HP:0032517', 'Majocchis granuloma', 'MP:0005671', 'abnormal response to transplant', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609547, 'HP:0032517', 'Majocchis granuloma', 'MP:0001790', 'abnormal immune system physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(609548, 'HP:0007720', 'Flat cornea', 'MP:0006151', 'astigmatism', 0.4520547945205479, 14.022184767190119, 2.5176965372461564, 'UPHENO:0005998', 'abnormal shape of cornea'),
(609549, 'HP:0007720', 'Flat cornea', 'MP:0012174', 'flat head', 0.4126984126984127, 12.04236264912775, 2.2293191674665325, 'UPHENO:0082356', 'flat anatomical entity in independent continuant'),
(609550, 'HP:0007720', 'Flat cornea', 'MP:0012175', 'flat face', 0.4307692307692308, 12.04236264912775, 2.2776038494454816, 'UPHENO:0082356', 'flat anatomical entity in independent continuant'),
(609551, 'HP:0007720', 'Flat cornea', 'MP:0030047', 'flat forehead', 0.417910447761194, 12.04236264912775, 2.243352216393952, 'UPHENO:0082356', 'flat anatomical entity in independent continuant'),
(609552, 'HP:0010696', 'Polar cataract', 'MP:0010259', 'anterior polar cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609553, 'HP:0010696', 'Polar cataract', 'MP:0010254', 'nuclear cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609554, 'HP:0010696', 'Polar cataract', 'MP:0031432', 'cornea perforation', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(609555, 'HP:0010696', 'Polar cataract', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.40816326530612246, 8.423925443855504, 1.854275307460947, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(609556, 'HP:0010696', 'Polar cataract', 'MP:0005545', 'abnormal lens development', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609557, 'HP:0010696', 'Polar cataract', 'MP:0013732', 'mature cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609558, 'HP:0010696', 'Polar cataract', 'MP:0031498', 'abnormal cornea size', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(609559, 'HP:0010696', 'Polar cataract', 'MP:0009829', 'enlarged eye anterior chamber', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(609560, 'HP:0010696', 'Polar cataract', 'MP:0010257', 'posterior cortical cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609561, 'HP:0010696', 'Polar cataract', 'MP:0002794', 'lenticonus', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609562, 'HP:0010696', 'Polar cataract', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609563, 'HP:0010696', 'Polar cataract', 'MP:0003237', 'abnormal lens epithelium morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609564, 'HP:0010696', 'Polar cataract', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609565, 'HP:0010696', 'Polar cataract', 'MP:0010256', 'anterior cortical cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609566, 'HP:0010696', 'Polar cataract', 'MP:0010253', 'posterior subcapsular cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609567, 'HP:0010696', 'Polar cataract', 'MP:0031316', 'lentiglobus', 0.4117647058823529, 10.410750055107773, 2.070453919906488, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609568, 'HP:0010696', 'Polar cataract', 'MP:0003236', 'abnormal lens capsule morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609569, 'HP:0010696', 'Polar cataract', 'MP:0031345', 'developmental cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609570, 'HP:0010696', 'Polar cataract', 'MP:0001304', 'cataract', 0.47058823529411764, 12.214829845132515, 2.3975310678360002, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609571, 'HP:0010696', 'Polar cataract', 'MP:0010263', 'total cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609572, 'HP:0010696', 'Polar cataract', 'MP:0001306', 'small lens', 0.43636363636363634, 10.410750055107773, 2.1314015931587726, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609573, 'HP:0010696', 'Polar cataract', 'MP:0001303', 'abnormal lens morphology', 0.42, 10.410750055107773, 2.0910559588746698, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609574, 'HP:0010696', 'Polar cataract', 'MP:0002840', 'abnormal lens fiber morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609575, 'HP:0010696', 'Polar cataract', 'MP:0001305', 'enlarged lens', 0.43636363636363634, 10.410750055107773, 2.1314015931587726, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609576, 'HP:0010696', 'Polar cataract', 'MP:0020486', 'abnormal lens topology', 0.4074074074074074, 10.410750055107773, 2.059470001995169, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609577, 'HP:0010696', 'Polar cataract', 'MP:0010261', 'sutural cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609578, 'HP:0010696', 'Polar cataract', 'MP:0010258', 'polar cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609579, 'HP:0010696', 'Polar cataract', 'MP:0010260', 'posterior polar cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609580, 'HP:0010696', 'Polar cataract', 'MP:0010262', 'lamellar cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609581, 'HP:0010696', 'Polar cataract', 'MP:0010252', 'anterior subcapsular cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609582, 'HP:0010696', 'Polar cataract', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609583, 'HP:0010696', 'Polar cataract', 'MP:0003847', 'disorganized lens bow', 0.4117647058823529, 10.410750055107773, 2.070453919906488, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609584, 'HP:0010696', 'Polar cataract', 'MP:0010255', 'cortical cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609585, 'HP:0010696', 'Polar cataract', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609586, 'HP:0010696', 'Polar cataract', 'MP:0010251', 'subcapsular cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609587, 'HP:0010696', 'Polar cataract', 'MP:0008841', 'ruptured lens capsule', 0.43636363636363634, 10.410750055107773, 2.1314015931587726, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609588, 'HP:0010696', 'Polar cataract', 'MP:0031317', 'spherophakia', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(609589, 'HP:0010696', 'Polar cataract', 'MP:0013731', 'immature cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(609590, 'HP:0033313', 'Urinary space collagenization', 'MP:0011360', 'kidney cortex hypoplasia', 0.40816326530612246, 10.972941248170269, 2.1163061049539635, 'UPHENO:0019594', 'abnormal cortex of kidney morphology'),
(609591, 'HP:0033313', 'Urinary space collagenization', 'MP:0003197', 'nephrocalcinosis', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(609592, 'HP:0033313', 'Urinary space collagenization', 'MP:0002956', 'decreased compensatory renal growth', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(609593, 'HP:0033313', 'Urinary space collagenization', 'MP:0009641', 'kidney degeneration', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(609594, 'HP:0033313', 'Urinary space collagenization', 'MP:0011293', 'dilated nephron', 0.4166666666666667, 8.69825431939161, 1.9037522509717062, 'UPHENO:0076756', 'abnormal nephron morphology'),
(609595, 'HP:0033313', 'Urinary space collagenization', 'MP:0003881', 'abnormal nephron morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(609596, 'HP:0033313', 'Urinary space collagenization', 'MP:0002706', 'abnormal kidney size', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(609597, 'HP:0033313', 'Urinary space collagenization', 'MP:0011377', 'renal glomerulus fibrosis', 0.40384615384615385, 9.252530554317739, 1.9330284213392313, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(609598, 'HP:0033313', 'Urinary space collagenization', 'MP:0002955', 'increased compensatory renal growth', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(609599, 'HP:0033313', 'Urinary space collagenization', 'MP:0004968', 'kidney epithelium hyperplasia', 0.40425531914893614, 8.472720947690348, 1.850714054295919, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(609600, 'HP:0033313', 'Urinary space collagenization', 'MP:0003985', 'renal fibrosis', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(609601, 'HP:0002126', 'Polymicrogyria', 'MP:0000791', 'delaminated cerebral cortex', 0.4230769230769231, 9.50911518495075, 2.005763493942646, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(609602, 'HP:0002126', 'Polymicrogyria', 'MP:0020569', 'abnormal premotor cortex size', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(609603, 'HP:0002126', 'Polymicrogyria', 'MP:0020066', 'abnormal neocortex size', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(609604, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0004662', 'abnormal thyroid diverticulum morphology', 0.4444444444444444, 11.668547812575419, 2.277283743856597, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609605, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0013235', 'abnormal thyroglossal duct morphology', 0.43243243243243246, 11.668547812575419, 2.2462988477818633, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609606, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0013162', 'abnormal thyroid gland isthmus morphology', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609607, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0004663', 'athyroidism', 0.47058823529411764, 11.668547812575419, 2.3433056402366517, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609608, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0013560', 'abnormal endocrine gland morphology', 0.4375, 7.914822368502075, 1.8608424936623889, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609609, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0003421', 'abnormal thyroid gland development', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609610, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0004696', 'abnormal thyroid follicle morphology', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609611, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0013937', 'absent lobe of thyroid gland', 0.47058823529411764, 11.668547812575419, 2.3433056402366517, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609612, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0000681', 'abnormal thyroid gland morphology', 0.48484848484848486, 11.668547812575419, 2.3785452964594334, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609613, 'HP:0002895', 'Papillary thyroid carcinoma', 'MP:0013528', 'thyroid gland cyst', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609614, 'HP:0040099', 'Abnormality of the round window', 'MP:0000049', 'abnormal middle ear morphology', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(609615, 'HP:0040099', 'Abnormality of the round window', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(609616, 'HP:0040099', 'Abnormality of the round window', 'MP:0003938', 'abnormal ear development', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(609617, 'HP:0040099', 'Abnormality of the round window', 'MP:0030228', 'absent tubotympanic recess', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(609618, 'HP:0040099', 'Abnormality of the round window', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(609619, 'HP:0040099', 'Abnormality of the round window', 'MP:0000020', 'scaly ears', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(609620, 'HP:0040099', 'Abnormality of the round window', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(609621, 'HP:0040099', 'Abnormality of the round window', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(609622, 'HP:0040099', 'Abnormality of the round window', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.4358974358974359, 7.8051695233081215, 1.8445198242238607, 'UPHENO:0076730', 'abnormal ear morphology'),
(609623, 'HP:0040099', 'Abnormality of the round window', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(609624, 'HP:0040099', 'Abnormality of the round window', 'MP:0030413', 'tympanic membrane retraction', 0.425, 9.948935785159481, 2.056282497297679, 'UPHENO:0003017', 'abnormal middle ear'),
(609625, 'HP:0040099', 'Abnormality of the round window', 'MP:0002859', 'abnormal inner ear canal fusion', 0.4358974358974359, 7.8051695233081215, 1.8445198242238607, 'UPHENO:0076730', 'abnormal ear morphology'),
(609626, 'HP:0040099', 'Abnormality of the round window', 'MP:0030092', 'abnormal outer ear helix morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(609627, 'HP:0040099', 'Abnormality of the round window', 'MP:0020304', 'abnormal horn morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(609628, 'HP:0040099', 'Abnormality of the round window', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(609629, 'HP:0040099', 'Abnormality of the round window', 'MP:0030226', 'middle ear polyps', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(609630, 'HP:0040099', 'Abnormality of the round window', 'MP:0000026', 'abnormal inner ear morphology', 0.4722222222222222, 7.8051695233081215, 1.9198371017140292, 'UPHENO:0076730', 'abnormal ear morphology'),
(609631, 'HP:0040099', 'Abnormality of the round window', 'MP:0030324', 'abnormal anterior head development', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(609632, 'HP:0040099', 'Abnormality of the round window', 'MP:0011238', 'abnormal inner ear development', 0.4473684210526316, 7.8051695233081215, 1.8686322178776849, 'UPHENO:0076730', 'abnormal ear morphology'),
(609633, 'HP:0040099', 'Abnormality of the round window', 'MP:0002102', 'abnormal ear morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(609634, 'HP:0040099', 'Abnormality of the round window', 'MP:0030161', 'absent auditory bulla', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(609635, 'HP:0040099', 'Abnormality of the round window', 'MP:0004427', 'abnormal vestibular labyrinth morphology', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(609636, 'HP:0040099', 'Abnormality of the round window', 'MP:0002177', 'abnormal outer ear morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(609637, 'HP:0040099', 'Abnormality of the round window', 'MP:0030160', 'abnormal auditory bulla morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(609638, 'HP:0040099', 'Abnormality of the round window', 'MP:0002729', 'abnormal inner ear canal morphology', 0.4473684210526316, 7.8051695233081215, 1.8686322178776849, 'UPHENO:0076730', 'abnormal ear morphology'),
(609639, 'HP:0040099', 'Abnormality of the round window', 'MP:0012176', 'abnormal head development', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(609640, 'HP:0040099', 'Abnormality of the round window', 'MP:0000432', 'abnormal head morphology', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(609641, 'HP:0040099', 'Abnormality of the round window', 'MP:0003330', 'abnormal auditory tube morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(609642, 'HP:0040099', 'Abnormality of the round window', 'MP:0006287', 'inner ear cyst', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(609643, 'HP:0040099', 'Abnormality of the round window', 'MP:0020290', 'floppy ears', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(609644, 'HP:0040099', 'Abnormality of the round window', 'MP:0003737', 'ossification of pinnae', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(609645, 'HP:0040099', 'Abnormality of the round window', 'MP:0004426', 'abnormal cochlear labyrinth morphology', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(609646, 'HP:0040099', 'Abnormality of the round window', 'MP:0003677', 'abnormal ear lobe morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(609647, 'HP:0031932', 'Aorto-left ventricular tunnel', 'MP:0012562', 'blood vessel degeneration', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(609648, 'HP:0031932', 'Aorto-left ventricular tunnel', 'MP:0000265', 'blood vessel atresia', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(609649, 'HP:0001492', 'Axenfeld anomaly', 'MP:0002697', 'abnormal eye size', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609650, 'HP:0001492', 'Axenfeld anomaly', 'MP:0006225', 'ocular rupture', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609651, 'HP:0001492', 'Axenfeld anomaly', 'MP:0006249', 'phthisis bulbi', 0.44642857142857145, 9.255471829629862, 2.0327092922498893, 'UPHENO:0072814', 'abnormally formed anatomical entity in independent continuant'),
(609652, 'HP:0001492', 'Axenfeld anomaly', 'MP:0009829', 'enlarged eye anterior chamber', 0.43103448275862066, 12.384754846574827, 2.310466705967801, 'UPHENO:0021670', 'abnormal anterior chamber of eyeball morphology'),
(609653, 'HP:0001492', 'Axenfeld anomaly', 'MP:0031213', 'increased eye anterior chamber depth', 0.4166666666666667, 12.384754846574827, 2.271632566989252, 'UPHENO:0021670', 'abnormal anterior chamber of eyeball morphology'),
(609654, 'HP:0001492', 'Axenfeld anomaly', 'MP:0006209', 'calcified intraocular region', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(609655, 'HP:0034974', 'Bathrocephaly', 'MP:0010031', 'abnormal cranium size', 0.42857142857142855, 7.173214147510782, 1.7533495471945912, 'UPHENO:0081566', 'abnormal skull morphology'),
(609656, 'HP:0034974', 'Bathrocephaly', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(609657, 'HP:0034974', 'Bathrocephaly', 'MP:0000919', 'cranioschisis', 0.42, 7.173214147510782, 1.7357274964563212, 'UPHENO:0081566', 'abnormal skull morphology'),
(609658, 'HP:0012810', 'Wide nasal base', 'MP:0030071', 'abnormal face shape', 0.4318181818181818, 5.913369942082322, 1.5979676645064742, 'UPHENO:0087472', 'abnormal face morphology'),
(609659, 'HP:0012810', 'Wide nasal base', 'MP:0030064', 'small face', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609660, 'HP:0012810', 'Wide nasal base', 'MP:0008862', 'asymmetric snout', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609661, 'HP:0012810', 'Wide nasal base', 'MP:0003743', 'abnormal facial morphology', 0.43243243243243246, 5.913369942082322, 1.5991037952326579, 'UPHENO:0087472', 'abnormal face morphology'),
(609662, 'HP:0012810', 'Wide nasal base', 'MP:0030042', 'large forehead', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(609663, 'HP:0012810', 'Wide nasal base', 'MP:0003671', 'abnormal eyelid aperture', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(609664, 'HP:0012810', 'Wide nasal base', 'MP:0006164', 'ectropion', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(609665, 'HP:0012810', 'Wide nasal base', 'MP:0031503', 'abnormal mouth size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(609666, 'HP:0012810', 'Wide nasal base', 'MP:0006209', 'calcified intraocular region', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609667, 'HP:0012810', 'Wide nasal base', 'MP:0002697', 'abnormal eye size', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609668, 'HP:0012810', 'Wide nasal base', 'MP:0030217', 'abnormal piriform aperture morphology', 0.4186046511627907, 9.78271883249473, 2.023633268233185, 'UPHENO:0087950', 'abnormal nose morphology'),
(609669, 'HP:0012810', 'Wide nasal base', 'MP:0030043', 'small forehead', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(609670, 'HP:0012810', 'Wide nasal base', 'MP:0002233', 'abnormal nose morphology', 0.42857142857142855, 9.78271883249473, 2.0475824245570395, 'UPHENO:0087950', 'abnormal nose morphology'),
(609671, 'HP:0012810', 'Wide nasal base', 'MP:0030095', 'abnormal midface morphology', 0.41025641025641024, 5.913369942082322, 1.557561531675988, 'UPHENO:0087472', 'abnormal face morphology'),
(609672, 'HP:0012810', 'Wide nasal base', 'MP:0001788', 'periorbital edema', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(609673, 'HP:0012810', 'Wide nasal base', 'MP:0030068', 'large face', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609674, 'HP:0012810', 'Wide nasal base', 'MP:0030045', 'abnormal forehead shape', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(609675, 'HP:0012810', 'Wide nasal base', 'MP:0030117', 'bifid nose', 0.43137254901960786, 11.126020578174659, 2.190766956399474, 'UPHENO:0021517', 'abnormal nose morphology'),
(609676, 'HP:0012810', 'Wide nasal base', 'MP:0008863', 'craniofacial asymmetry', 0.4146341463414634, 4.6730878730104815, 1.3919848422322514, 'UPHENO:0087907', 'abnormal head morphology'),
(609677, 'HP:0012810', 'Wide nasal base', 'MP:0030041', 'abnormal forehead size', 0.4418604651162791, 5.913369942082322, 1.6164418928662792, 'UPHENO:0087472', 'abnormal face morphology'),
(609678, 'HP:0012810', 'Wide nasal base', 'MP:0013788', 'external nares atresia', 0.40384615384615385, 9.78271883249473, 1.9876401522059604, 'UPHENO:0087950', 'abnormal nose morphology'),
(609679, 'HP:0012810', 'Wide nasal base', 'MP:0011496', 'abnormal head size', 0.4358974358974359, 4.6730878730104815, 1.4272305425433802, 'UPHENO:0087907', 'abnormal head morphology'),
(609680, 'HP:0012810', 'Wide nasal base', 'MP:0030063', 'abnormal face size', 0.4634146341463415, 5.913369942082322, 1.6553978882075608, 'UPHENO:0087472', 'abnormal face morphology'),
(609681, 'HP:0012810', 'Wide nasal base', 'MP:0030313', 'abnormal face development', 0.41025641025641024, 5.913369942082322, 1.557561531675988, 'UPHENO:0087472', 'abnormal face morphology'),
(609682, 'HP:0012810', 'Wide nasal base', 'MP:0011495', 'abnormal head shape', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(609683, 'HP:0012810', 'Wide nasal base', 'MP:0030074', 'coarse facial features', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609684, 'HP:0012810', 'Wide nasal base', 'MP:0030190', 'small snout', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(609685, 'HP:0012810', 'Wide nasal base', 'MP:0006225', 'ocular rupture', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(609686, 'HP:0012810', 'Wide nasal base', 'MP:0031101', 'nasal obstruction', 0.42, 9.78271883249473, 2.027003184419745, 'UPHENO:0087950', 'abnormal nose morphology'),
(609687, 'HP:0012810', 'Wide nasal base', 'MP:0030218', 'piriform aperture stenosis', 0.4090909090909091, 9.78271883249473, 2.000505271316731, 'UPHENO:0087950', 'abnormal nose morphology'),
(609688, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0004663', 'athyroidism', 0.47058823529411764, 11.668547812575419, 2.3433056402366517, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609689, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0008300', 'enlarged adrenal medulla', 0.40476190476190477, 7.914822368502075, 1.7898655194530761, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609690, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0003112', 'enlarged parathyroid gland', 0.425, 7.914822368502075, 1.8340663855524373, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609691, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0004661', 'absent thyroid parafollicular C-cells', 0.46153846153846156, 11.668547812575419, 2.3206644750596843, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609692, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013235', 'abnormal thyroglossal duct morphology', 0.43243243243243246, 11.668547812575419, 2.2462988477818633, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609693, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0000642', 'enlarged adrenal glands', 0.4146341463414634, 7.914822368502075, 1.8115616512302797, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609694, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0009254', 'disorganized pancreatic islets', 0.40476190476190477, 7.914822368502075, 1.7898655194530761, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609695, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0009170', 'abnormal pancreatic islet size', 0.40476190476190477, 7.914822368502075, 1.7898655194530761, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609696, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0002768', 'small adrenal glands', 0.4146341463414634, 7.914822368502075, 1.8115616512302797, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609697, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013937', 'absent lobe of thyroid gland', 0.47058823529411764, 11.668547812575419, 2.3433056402366517, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609698, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0020169', 'increased thyroid gland weight', 0.4523809523809524, 11.668547812575419, 2.2975266641228664, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609699, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0000681', 'abnormal thyroid gland morphology', 0.48484848484848486, 11.668547812575419, 2.3785452964594334, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609700, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0005355', 'enlarged thyroid gland', 0.5, 11.668547812575419, 2.415424166950333, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609701, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0002951', 'small thyroid gland', 0.5, 11.668547812575419, 2.415424166950333, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609702, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0004662', 'abnormal thyroid diverticulum morphology', 0.4444444444444444, 11.668547812575419, 2.277283743856597, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609703, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0020168', 'decreased thyroid gland weight', 0.4318181818181818, 11.668547812575419, 2.244702898132588, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609704, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0004697', 'abnormal thyroid follicular cell morphology', 0.4358974358974359, 11.668547812575419, 2.25528048635824, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609705, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013560', 'abnormal endocrine gland morphology', 0.4375, 7.914822368502075, 1.8608424936623889, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609706, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0003499', 'thyroid gland hypoplasia', 0.4418604651162791, 11.668547812575419, 2.270654082791149, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609707, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013572', 'abnormal parathyroid gland chief cell morphology', 0.40476190476190477, 7.914822368502075, 1.7898655194530761, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609708, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013528', 'thyroid gland cyst', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609709, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0004696', 'abnormal thyroid follicle morphology', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609710, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0003113', 'small parathyroid gland', 0.425, 7.914822368502075, 1.8340663855524373, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(609711, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013162', 'abnormal thyroid gland isthmus morphology', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609712, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0004698', 'abnormal thyroid parafollicular C-cell morphology', 0.47368421052631576, 11.668547812575419, 2.3510012459776273, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609713, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0003421', 'abnormal thyroid gland development', 0.45714285714285713, 11.668547812575419, 2.309587254413386, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609714, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0013233', 'ectopic thyroid gland', 0.4358974358974359, 11.668547812575419, 2.25528048635824, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609715, 'HP:0008188', 'Thyroid dysgenesis', 'MP:0003498', 'thyroid gland hyperplasia', 0.4634146341463415, 11.668547812575419, 2.325376488997799, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(609716, 'HP:0031230', 'Decreased incisura length', 'MP:0000053', 'excessive ear growth', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(609717, 'HP:0031230', 'Decreased incisura length', 'MP:0006290', 'proboscis', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(609718, 'HP:0031230', 'Decreased incisura length', 'MP:0011495', 'abnormal head shape', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(609719, 'HP:0031230', 'Decreased incisura length', 'MP:0003735', 'cup-shaped ears', 0.5098039215686274, 12.607147267911277, 2.5351869984232676, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(609720, 'HP:0031230', 'Decreased incisura length', 'MP:0000022', 'abnormal ear shape', 0.5434782608695652, 11.115294171581601, 2.457828461350544, 'UPHENO:0005986', 'abnormal shape of external ear'),
(609721, 'HP:0031230', 'Decreased incisura length', 'MP:0000018', 'small ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(609722, 'HP:0031230', 'Decreased incisura length', 'MP:0003736', 'folded helix', 0.4642857142857143, 12.607147267911277, 2.419363216713724, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(609723, 'HP:0031230', 'Decreased incisura length', 'MP:0030071', 'abnormal face shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(609724, 'HP:0031230', 'Decreased incisura length', 'MP:0009578', 'otocephaly', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(609725, 'HP:0031230', 'Decreased incisura length', 'MP:0030092', 'abnormal outer ear helix morphology', 0.41304347826086957, 12.607147267911277, 2.2819509106212372, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(609726, 'HP:0031230', 'Decreased incisura length', 'MP:0000017', 'big ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(609727, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609728, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014256', 'decreased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609729, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003477', 'abnormal nerve fiber response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609730, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609731, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609732, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609733, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003466', 'decreased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609734, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609735, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010149', 'abnormal synaptic dopamine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
